Exostart Second Trial

Third trial

Site Auto populate Feature

Site Auto populate Feature

New Study

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease  

This is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's disease.

Acne study trial  

Acne study trial

check prescreener translation  

check prescreener translation

Referral_Trial 01  

qa1

T2  

Q1

Trial_T2DQ  

Test Comment here